Status of hospital-based blood transfusion services in low-income and middle-income countries: a cross-sectional international survey
- PMID: 35168978
- PMCID: PMC8852762
- DOI: 10.1136/bmjopen-2021-055017
Status of hospital-based blood transfusion services in low-income and middle-income countries: a cross-sectional international survey
Abstract
Objectives: Blood transfusion is life-saving for patients experiencing acute blood loss and severe anaemia. In low-income and middle-income countries (LMICs), low blood donation rates and unavailability of whole blood and blood components (blood products) impairs timely blood transfusion. To fulfil patient-specific blood orders, a hospital blood transfusion service (HBTS) receives orders from a prescriber for blood transfusion, tests and prepares blood products for the patient. This study sought to describe the current state of LMIC HBTS.
Design: A cross-sectional survey explored LMIC HBTS access to blood products, testing methods, policies and structure. Surveys were administered in English, Spanish, French and Russian, followed by a mixed-methods analysis.
Setting: HBTS within LMICs.
Participants: From among 124 public and private facilities invited to participate, we received 71 (57%) responses. Of these responses, 50 HBTS from 27 LMICs performed on-site blood transfusions.
Results: Most LMIC HBTS perform blood collection to generate blood products for their patients (36/47, 77%); few relied exclusively on an external supply of blood products (11/47, 23%). The primary reason for blood transfusion was adult anaemia for non-malignant conditions (17/112, 15%). Testing methods varied by gross national income per capita. Blood transfusion delays to patients were common (17/30, 57%) attributed to inadequate blood inventories (13/29, 45%). Other barriers included lack of regular clinician education about transfusion (8/29, 28%) and sustainable financial models for the HBTS (4/29, 14%).
Conclusion: This survey describes the status of HBTS in diverse LMICs, illustrating that the availability of blood products remains a principal problem, requiring HBTS to generate its own facility's blood supply. Currently, blood shortages are not reported as a patient-specific adverse event making systematic tracking of delays in transfusion difficult. These findings highlight areas for further exploration related to the lack of available blood inventories for transfusions at HBTS in LMICs.
Keywords: blood bank & transfusion medicine; health policy; health services administration & management; organisation of health services; public health.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: LSB reports personal fees and non-financial support from X-CellSystem, GLG, and AABB; LSB is a technical advisor to PAHO. JS is a contractor at Roche Molecular Systems. EB reports personal fees and non-financial support from Terumo BCT, Grifols Diagnostics Solutions and Abbott Laboratories outside of the submitted work; EB is a member of the US Food and Drug Administration (FDA) Blood Products Advisory Committee. TSI is a consultant for Terumo Blood Cell Technologies and Alexion Pharmaceuticals Inc.
Figures



Similar articles
-
COVID-19 and the impact on blood availability and transfusion practices in low- and middle-income countries.Transfusion. 2022 Feb;62(2):336-345. doi: 10.1111/trf.16798. Epub 2022 Jan 13. Transfusion. 2022. PMID: 35023585
-
The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults.Lancet. 2019 Aug 24;394(10199):652-662. doi: 10.1016/S0140-6736(19)30955-9. Epub 2019 Jul 18. Lancet. 2019. PMID: 31327566
-
Evaluation of blood product transfusion therapies in acute injury care in low- and middle-income countries: a systematic review.Injury. 2020 Jul;51(7):1468-1476. doi: 10.1016/j.injury.2020.05.007. Epub 2020 May 7. Injury. 2020. PMID: 32409189
-
Global Barriers to Otolaryngology Care.JAMA Otolaryngol Head Neck Surg. 2025 Jun 1;151(6):604-614. doi: 10.1001/jamaoto.2025.0573. JAMA Otolaryngol Head Neck Surg. 2025. PMID: 40272811
-
Barriers to COVID-19 Health Products in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Rapid Systematic Review and Evidence Synthesis.Front Public Health. 2022 Jul 22;10:928065. doi: 10.3389/fpubh.2022.928065. eCollection 2022. Front Public Health. 2022. PMID: 35937225 Free PMC article.
Cited by
-
How ready is the health care system in Northeast India for surgical delivery? a mixed-methods study on surgical capacity and need.PLoS One. 2024 Jun 26;19(6):e0287941. doi: 10.1371/journal.pone.0287941. eCollection 2024. PLoS One. 2024. PMID: 38924079 Free PMC article.
-
Crystalloid resuscitation is associated with decreased treatment delays and improved systolic blood pressures in a blood-constrained setting.Trauma Surg Acute Care Open. 2024 Apr 9;9(1):e001290. doi: 10.1136/tsaco-2023-001290. eCollection 2024. Trauma Surg Acute Care Open. 2024. PMID: 38616791 Free PMC article.
-
Red blood cell transfusion in a tertiary Haitian hospital's emergency department: patient characteristics and availability challenges.Int J Emerg Med. 2024 Sep 27;17(1):128. doi: 10.1186/s12245-024-00672-8. Int J Emerg Med. 2024. PMID: 39333880 Free PMC article.
-
Big Data in Transfusion Medicine and Artificial Intelligence Analysis for Red Blood Cell Quality Control.Transfus Med Hemother. 2023 May 25;50(3):163-173. doi: 10.1159/000530458. eCollection 2023 Jun. Transfus Med Hemother. 2023. PMID: 37408647 Free PMC article. Review.
-
Prevention of Blood Incompatibility Related Hemagglutination: Blocking of Antigen A on Red Blood Cells Using In Silico Designed Recombinant Anti-A scFv.Antibodies (Basel). 2024 Aug 1;13(3):64. doi: 10.3390/antib13030064. Antibodies (Basel). 2024. PMID: 39189235 Free PMC article.
References
-
- WHO . World health organization model list of essential medicines. Mental and Holistic Health: Some International Perspectives, 2019: 119–34.
-
- World Health Organization (WHO). . Global status report on blood safety and availability 2016. Geneva: World Health Organization, 2017.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources